Literature DB >> 18424076

Thrombocytopenia during levetiracetam therapy.

A Meschede1, U Runge, M Sabolek.   

Abstract

A 64-year-old patient with symptomatic epilepsy developed thrombocytopenia during treatment with levetiracetam (LEV). As no other medical reason could be evaluated, a medication side effect was postulated. The only new drugs were valproic acid (since 3 weeks) and levetiracetam (since 3 days). After valproic acid medication was ended, thrombocytopenia did not improve and even worsened further. Finally levetiracetam administration was ended and trombocytopenia resolved rapidly and completely within few days.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18424076     DOI: 10.1016/j.eplepsyres.2008.03.002

Source DB:  PubMed          Journal:  Epilepsy Res        ISSN: 0920-1211            Impact factor:   3.045


  8 in total

1.  Impact of antiepileptic drugs on thrombocytopenia in glioblastoma patients treated with standard chemoradiotherapy.

Authors:  Marta Simó; Roser Velasco; Francesc Graus; Eugenia Verger; Miguel Gil; Estela Pineda; Jaume Blasco; Jordi Bruna
Journal:  J Neurooncol       Date:  2012-03-10       Impact factor: 4.130

2.  Pancytopenia associated with levetiracetam in an epileptic woman.

Authors:  Rafael García Carretero; Marta Romero Brugera; Monica Olid-Velilla; Inmaculada Salamanca-Ramirez
Journal:  BMJ Case Rep       Date:  2016-12-07

3.  Haematological toxicity of Valproic acid compared to Levetiracetam in patients with glioblastoma multiforme undergoing concomitant radio-chemotherapy: a retrospective cohort study.

Authors:  Alexander Tinchon; Stefan Oberndorfer; Christine Marosi; Andreas Gleiss; Angelika Geroldinger; Cornelia Sax; Camillo Sherif; Walter Moser; Wolfgang Grisold
Journal:  J Neurol       Date:  2014-10-31       Impact factor: 4.849

4.  Pancytopenia associated with levetiracetam treatment.

Authors:  Massimo Gallerani; Elisa Mari; Benedetta Boari; Rossella Carletti; Anna Marra; Michele Cavallo
Journal:  Clin Drug Investig       Date:  2009       Impact factor: 2.859

5.  Delayed Recognition of Levetiracetam-induced Pancytopenia.

Authors:  Mohammad Ammad Ud Din; Syed Ather Hussain; Amy Bodrog
Journal:  Eur J Case Rep Intern Med       Date:  2021-03-30

6.  B cell aplasia and hypogammaglobulinemia associated with levetiracetam.

Authors:  Hulya Ozdemir; Sua Sumer; Hakan Karabagli; Gokhan Akdemir; A Zafer Caliskaner; Hasibe Artac
Journal:  Ann Saudi Med       Date:  2018-01-09       Impact factor: 1.526

7.  Associations of levetiracetam use with the safety and tolerability profile of chemoradiotherapy for patients with newly diagnosed glioblastoma.

Authors:  Katharina Seystahl; Felix Boakye Oppong; Emilie Le Rhun; Caroline Hertler; Roger Stupp; Burt Nabors; Olivier Chinot; Matthias Preusser; Thierry Gorlia; Michael Weller
Journal:  Neurooncol Adv       Date:  2022-07-07

8.  Levetiracetam in the Treatment of Epileptic Seizures After Liver Transplantation.

Authors:  Chih-Hsiang Lin; Chao-Long Chen; Tsu-Kung Lin; Nai-Ching Chen; Meng-Han Tsai; Yao-Chung Chuang
Journal:  Medicine (Baltimore)       Date:  2015-09       Impact factor: 1.817

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.